Pyridoxal 5'-phosphate (PLP) deficiency might contribute to the onset of type I diabetes

Medical Hypotheses

Volumn 78, Issue 1, 2012, Pages 179-182

  Rubi B ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DECARBOXYLASE; GLUTAMATE DECARBOXYLASE; PYRIDOXAL 5 PHOSPHATE;

ALCOHOL CONSUMPTION; ARTICLE; AUTOIMMUNITY; BINDING SITE; DOPAMINE METABOLISM; FAMILY HISTORY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PROTEIN FUNCTION; PROTEIN STRUCTURE; PYRIDOXINE DEFICIENCY; SYNTHESIS;

AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; MODELS, BIOLOGICAL; PYRIDOXAL PHOSPHATE;

EID: 83155173945     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.10.021     Document Type: Article

References (42)

1. Rorsman F., Husebye E.S., Winqvist O., Bjork E., Karlsson F.A., Kampe O. Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci USA 1995, 92:8626-8629.
2. Rubi B., Ljubicic S., Pournourmohammadi S., Carobbio S., Armanet M., Bartley C., et al. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 2005, 280:36824-36832.
3. Matsuda N., Hayashi H., Miyatake S., Kuroiwa T., Kagamiyama H. Instability of the apo form of aromatic L-amino acid decarboxylase in vivo and in vitro: implications for the involvement of the flexible loop that covers the active site. J Biochem 2004, 135:33-42.
4. Allen G.F., Neergheen V., Oppenheim M., Fitzgerald J.C., Footitt E., Hyland K., et al. Pyridoxal 5'-phosphate deficiency causes a loss of aromatic L-amino acid decarboxylase in patients and human neuroblastoma cells, implications for aromatic L-amino acid decarboxylase and vitamin B(6) deficiency states. J Neurochem 2010, 114:87-96.
5. Larsson S.C., Orsini N., Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 2010, 303:1077-1083.
6. Lundgren V.M., Isomaa B., Lyssenko V., Laurila E., Korhonen P., Groop L.C., et al. GAD antibody positivity predicts type 2 diabetes in an adult population. Diabetes 2010, 59:416-422.
7. Bhat R., Axtell R., Mitra A., Miranda M., Lock C., Tsien R.W., et al. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA 2010, 107:2580-2585.
8. Harjutsalo V., Sjoberg L., Tuomilehto J. Time trends in the incidence of type 1 diabetes in finnish children: a cohort study. Lancet 2008, 371:1777-1782.
9. Rubi B., Maechler P. Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance. Endocrinology 2010, 151:5570-5581.
10. Geng L., Solimena M., Flavell R.A., Sherwin R.S., Hayday A.C. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease. Proc Natl Acad Sci USA 1998, 95:10055-10060.
11. Arafat Y., Fenalti G., Whisstock J.C., Mackay I.R., Garcia de la Banda M., Rowley M.J., et al. Structural determinants of GAD antigenicity. Mol Immunol 2009, 47:493-505.
12. Fenalti G., Hampe C.S., Arafat Y., Law R.H., Banga J.P., Mackay I.R., et al. COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes 2008, 57:1293-1301.
13. Chen C.H., Wu S.J., Martin D.L. Structural characteristics of brain glutamate decarboxylase in relation to its interaction and activation. Arch Biochem Biophys 1998, 349:175-182.
14. Sun Q., Collins R., Huang S., Holmberg-Schiavone L., Anand G.S., Tan C.H., et al. Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S. J Biol Chem 2009, 284:3076-3085.
15. Nishio K., Ogasahara K., Morimoto Y., Tsukihara T., Lee S.J., Yutani K. Large conformational changes in the Escherichia coli tryptophan synthase beta(2) subunit upon pyridoxal 5'-phosphate binding. Febs J 2010, 277:2157-2170.
16. Watanabe N., Clay M.D., van Belkum M.J., Cherney M.M., Vederas J.C., James M.N. Mechanism of substrate recognition and PLP-induced conformational changes in LL-diaminopimelate aminotransferase from Arabidopsis thaliana. J Mol Biol 2008, 384:1314-1329.
17. Battaglioli G., Liu H., Martin D.L. Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis. J Neurochem 2003, 86:879-887.
18. Khan M.W., Banga K., Mashal S.N., Khan W.A. Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications. BMC Immunol 2011, 12:19.
19. Lindstrom P. Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets. Biochim Biophys Acta 1986, 884:276-281.
20. Elstner M., Morris C.M., Heim K., Lichtner P., Bender A., Mehta D., et al. Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Ann Neurol 2009, 66:792-798.
21. Spiegel A., Shivtiel S., Kalinkovich A., Ludin A., Netzer N., Goichberg P., et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 2007, 8:1123-1131.
22. Yamamoto T., Yamato E., Tashiro F., Sato T., Noso S., Ikegami H., et al. Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice. Diabetologia 2004, 47:221-224.
23. Viglietta V., Kent S.C., Orban T., Hafler D.A. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 2002, 109:895-903.
24. Kirksey A., Keaton K., Abernathy R.P., Greger J.L. Vitamin B6 nutritional status of a group of female adolescents. Am J Clin Nutr 1978, 31:946-954.
25. Hagglof B., Blom L., Dahlquist G., Lonnberg G., Sahlin B. The Swedish childhood diabetes study: indications of severe psychological stress as a risk factor for type 1 (insulin-dependent) diabetes mellitus in childhood. Diabetologia 1991, 34:579-583.
26. Henrotte J.G., Franck G., Santarromana M., Nakib S., Dauchy F., Boulu R.G. Effect of pyridoxine on mice gastric ulcers and brain catecholamines after an immobilization stress. Ann Nutr Metab 1992, 36:313-317.
27. Ha C., Kerkvliet N.I., Miller L.T. The effect of vitamin B-6 deficiency on host susceptibility to Moloney sarcoma virus-induced tumor growth in mice. J Nutr 1984, 114:938-948.
28. Stene L.C., Oikarinen S., Hyoty H., Barriga K.J., Norris J.M., Klingensmith G., et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the diabetes and autoimmunity study in the young (DAISY). Diabetes 2010, 59:3174-3180.
29. Mitri J., Pittas A.G. Diabetes: shining a light: the role of vitamin D in diabetes mellitus. Nat Rev Endocrinol 2010, 6:478-480.
30. Marjamaki L., Niinisto S., Kenward M.G., Uusitalo L., Uusitalo U., Ovaskainen M.L., et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 2010, 53:1599-1607.
31. Hou C.T., Wu Y.H., Huang P.N., Cheng C.H., Huang Y.C. Higher plasma pyridoxal 5'-phosphate is associated with better blood glucose responses in critically ill surgical patients with inadequate vitamin B-6 status. Clin Nutr 2011.
32. Ye X., Maras J.E., Bakun P.J., Tucker K.L. Dietary intake of vitamin B-6, plasma pyridoxal 5'-phosphate, and homocysteine in Puerto Rican adults. J Am Diet Assoc 2010, 110:1660-1668.
33. Salih E.Y., Zein A.A., Bayoumi R.A. The effect of oral contraceptives on the apparent vitamin B6 status in some sudanese women. Br J Nutr 1986, 56:363-367.
34. Lussana F., Zighetti M.L., Bucciarelli P., Cugno M., Cattaneo M. Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users. Thromb Res 2003, 112:37-41.
35. Masse P.G., van den Berg H., Duguay C., Beaulieu G., Simard J.M. Early effect of a low dose (30 micrograms) ethinyl estradiol-containing triphasil on vitamin B6 status. A follow-up study on six menstrual cycles. Int J Vitam Nutr Res 1996, 66:46-54.
36. Oak S., Gilliam L.K., Landin-Olsson M., Torn C., Kockum I., Pennington C.R., et al. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci USA 2008, 105:5471-5476.
37. Gachon F., Fonjallaz P., Damiola F., Gos P., Kodama T., Zakany J., et al. The loss of circadian PAR bZip transcription factors results in epilepsy. Genes Dev 2004, 18:1397-1412.
38. Bass J., Takahashi J.S. Circadian integration of metabolism and energetics. Science 2010, 330:1349-1354.
39. Lumeng L., Li T.K. Vitamin B6 metabolism in chronic alcohol abuse. Pyridoxal phosphate levels in plasma and the effects of acetaldehyde on pyridoxal phosphate synthesis and degradation in human erythrocytes. J Clin Invest 1974, 53:693-704.
40. Parna K., Rahu K., Helakorpi S., Tekkel M. Alcohol consumption in Estonia and Finland: finbalt survey 1994-2006. BMC Public Health 2010, 10:261.
41. Heiskanen K., Siimes M.A., Salmenpera L., Perheentupa J. Low vitamin B6 status associated with slow growth in healthy breast-fed infants. Pediatr Res 1995, 38:740-746.
42. Gregory J.F. Nutritional properties and significance of vitamin glycosides. Annu Rev Nutr 1998, 18:277-296.